Alkeon Capital Management - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 156 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.

Quarter-by-quarter ownership
Alkeon Capital Management ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$12,613,000
+10.5%
1,961,5880.0%0.02%
+21.1%
Q3 2021$11,416,000
-58.5%
1,961,588
-26.3%
0.02%
-53.7%
Q2 2021$27,484,000
-2.1%
2,663,177
-0.2%
0.04%
-2.4%
Q1 2021$28,070,000
-32.0%
2,668,199
+0.1%
0.04%
-37.3%
Q4 2020$41,276,000
+30.6%
2,666,416
+23.2%
0.07%
+13.6%
Q3 2020$31,608,000
-19.2%
2,164,900
+4.8%
0.06%
-40.4%
Q2 2020$39,110,000
-6.0%
2,064,900
-4.6%
0.10%
-44.4%
Q1 2020$41,587,000
+1635.7%
2,164,900
+1631.9%
0.18%
+1877.8%
Q4 2019$2,396,000125,0000.01%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders